TP53 and lung carcinoma: Given that a group of researchers recently found that ZnO (50 μg/mL) induces DNA damage in A549 (human lung carcinoma) cells [32], we conjecture that the ZnO treatment in our experiments might have resulted in DNA damage, which then upregulated the transcripts in the p53 pathway.